BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3403839)

  • 1. Amiodarone pulmonary toxicity: prospective evaluation of serial pulmonary function tests.
    Magro SA; Lawrence EC; Wheeler SH; Krafchek J; Lin HT; Wyndham CR
    J Am Coll Cardiol; 1988 Sep; 12(3):781-8. PubMed ID: 3403839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial lung function testing in patients treated with amiodarone: a prospective study.
    Gleadhill IC; Wise RA; Schonfeld SA; Scott PP; Guarnieri T; Levine JH; Griffith LS; Veltri EP
    Am J Med; 1989 Jan; 86(1):4-10. PubMed ID: 2910095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective evaluation of amiodarone pulmonary toxicity.
    Kudenchuk PJ; Pierson DJ; Greene HL; Graham EL; Sears GK; Trobaugh GB
    Chest; 1984 Oct; 86(4):541-8. PubMed ID: 6478892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone.
    Yamada Y; Shiga T; Matsuda N; Hagiwara N; Kasanuki H
    Circ J; 2007 Oct; 71(10):1610-6. PubMed ID: 17895560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of amiodarone-induced pulmonary toxicity.
    Dusman RE; Stanton MS; Miles WM; Klein LS; Zipes DP; Fineberg NS; Heger JJ
    Circulation; 1990 Jul; 82(1):51-9. PubMed ID: 2364524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
    Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
    Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone-induced pneumonitis. Assessment of risk factors and possible risk reduction.
    Adams GD; Kehoe R; Lesch M; Glassroth J
    Chest; 1988 Feb; 93(2):254-63. PubMed ID: 3338292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone pulmonary toxicity: a multidisciplinary review of current status.
    Fraire AE; Guntupalli KK; Greenberg SD; Cartwright J; Chasen MH
    South Med J; 1993 Jan; 86(1):67-77. PubMed ID: 8420020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of amiodarone hepatic and pulmonary toxicity to serum drug concentrations and superoxide dismutase activity.
    Pollak PT; Sharma AD; Carruthers SG
    Am J Cardiol; 1990 May; 65(18):1185-91. PubMed ID: 2337027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320).
    Singh SN; Fisher SG; Deedwania PC; Rohatgi P; Singh BN; Fletcher RD
    J Am Coll Cardiol; 1997 Aug; 30(2):514-7. PubMed ID: 9247526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rituximab on pulmonary function in patients with rheumatoid arthritis.
    Franzen D; Ciurea A; Bratton DJ; Clarenbach CF; Latshang TD; Russi EW; Kyburz D; Kohler M
    Pulm Pharmacol Ther; 2016 Apr; 37():24-9. PubMed ID: 26869014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone pulmonary toxicity.
    Rakita L; Sobol SM; Mostow N; Vrobel T
    Am Heart J; 1983 Oct; 106(4 Pt 2):906-16. PubMed ID: 6310979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial pulmonary function tests in patients treated with low-dose amiodarone.
    Ulrik CS; Backer V; Aldershvile J; Pietersen AH
    Am Heart J; 1992 Jun; 123(6):1550-4. PubMed ID: 1595534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
    Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
    Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone pulmonary toxicity: early changes in pulmonary function tests during amiodarone rechallenge.
    Veltri EP; Reid PR
    J Am Coll Cardiol; 1985 Oct; 6(4):802-5. PubMed ID: 4031295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallium lung scintigraphy in amiodarone pulmonary toxicity.
    Zhu YY; Botvinick E; Dae M; Golden J; Hattner R; Scheinman M
    Chest; 1988 Jun; 93(6):1126-31. PubMed ID: 3371091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of amiodarone-induced pulmonary toxicity: are repeated lung function tests of any value?].
    Ulrik CS; Aldershvile J
    Ugeskr Laeger; 1996 Jun; 158(24):3445-7. PubMed ID: 8650812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of serial pulmonary function testing as an indicator of amiodarone toxicity.
    Ohar JA; Jackson F; Redd RM; Evans GR; Bedrossian CW
    Am J Cardiol; 1989 Dec; 64(19):1322-6. PubMed ID: 2589198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic utility of chest computed tomography scoring for the assessment of amiodarone-induced pulmonary toxicity.
    Kang IS; Kim KJ; Kim Y; Park SH
    Korean J Intern Med; 2014 Nov; 29(6):746-53. PubMed ID: 25378973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary effects of low dose amiodarone: a review of the risks and recommendations for surveillance.
    Sunderji R; Kanji Z; Gin K
    Can J Cardiol; 2000 Nov; 16(11):1435-40. PubMed ID: 11109040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.